RecruitingNCT06699979

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Comprehensive Multi-Omics Analysis of Early-Stage Lung Cancer Exhibiting Distinct Phenotypes


Sponsor

Central South University

Enrollment

300 participants

Start Date

Aug 29, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to investigate the multi-omics characterization early-stage lung cancer exhibiting distinct phenotypes including lung cancer associated with cystic airspaces, multiple primary lung cancers, and so on. The main questions it aims to answer are: * What are the differences in pathogenesis of non-small cell lung cancer with different phenotypes explored by multi-omics? * Whether differential genes lead to potential prognostic models and therapeutic targets? Participants will be followed up after surgery to answer prognosis: whether they have recurred, and the time to recurrence.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting biological samples (such as tissue) from people with early-stage non-small cell lung cancer (NSCLC) to better understand different types of tumors — including cases where multiple lung cancers appear at once, and cases where lung cancer grows near air-filled cysts in the lung. **You may be eligible if...** - You are between 18 and 75 years old - You have been confirmed to have early-stage (Stage I or II) non-small cell lung cancer - You are in generally good physical condition (able to carry out normal daily activities) - You have either multiple lung cancers appearing at the same time, or a lung cancer associated with cyst-like airspaces on a CT scan **You may NOT be eligible if...** - You have a history of another cancer - You have already received chemotherapy, radiation, or targeted cancer treatment before joining the study - You do not wish to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06699979


Related Trials